Atherosclerosis development in SLE patients is not determined by monocytes ability to bind/endocytose Ox-LDL

References

• Hansson GK, Robertson AK, Soderberg-Naucler C. Inflammation and atherosclerosis. Annu Rev Pathol. 2006; 1:297–329.
   PubMed Web of Science ®Google Scholar
• Hahn BH, Grossman J, Chen W, McMahon M. The pathogenesis of atherosclerosis in autoimmune rheumatic diseases: Roles of inflammation and dyslipidemia. J Autoimmun. 2007; 28:69–75.
   PubMed Web of Science ®Google Scholar
• Cybulsky MI, Gimbrone MAJr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science. 1991; 251:788–791.
   PubMed Web of Science ®Google Scholar
• Lundberg AM, Hansson GK. Innate immune signals in atherosclerosis. Clin Immunol. 2010; 134:5–24.
   PubMed Web of Science ®Google Scholar
• Tulenko TN, Sumner AE. The physiology of lipoproteins. J Nucl Cardiol. 2002; 9:638–649.
   PubMed Web of Science ®Google Scholar
• Peiser L, Gordon S. The function of scavenger receptors expressed by macrophages and their role in the regulation of inflammation. Microbes Infect. 2001; 3:149–159.
   PubMed Web of Science ®Google Scholar
• Smith JD, Trogan E, Ginsberg M, Grigaux C, Tian J, Miyata M. Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E. Proc Natl Acad Sci USA. 1995; 92:8264–8268.
   PubMed Web of Science ®Google Scholar
• Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: Implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983; 52:223–261.
   PubMed Web of Science ®Google Scholar
• Sherer Y, Zinger H, Shoenfeld Y. Atherosclerosis in systemic lupus erythematosus. Autoimmunity. 2010; 43:98–102.
   PubMed Web of Science ®Google Scholar
• Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L, Simantov R, Crow MK, Schwartz JE, Paget SA, Devereux RB, Salmon JE. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med. 2003; 349:2399–2406.
   PubMed Web of Science ®Google Scholar
• Bernatsky S, Boivin JF, Joseph L, Manzi S, Ginzler E, Gladman DD, Urowitz M, Fortin PR, Petri M, Barr S, Gordon C, Bae SC, Isenberg D, Zoma A, Aranow C, Dooley MA, Nived O, Sturfelt G, Steinsson K, Alarcon G, Senecal JL, Zummer M, Hanly J, Ensworth S, Pope J, Edworthy S, Rahman A, Sibley J, El-Gabalawy H, McCarthy T, St Pierre Y, Clarke A, Ramsey-Goldman R. Mortality in systemic lupus erythematosus. Arthritis Rheum. 2006; 54:2550–2557.
   PubMed Web of Science ®Google Scholar
• Jonsson H, Nived O, Sturfelt G. Outcome in systemic lupus erythematosus: A prospective study of patients from a defined population. Medicine (Baltimore). 1989; 68:141–150.
   PubMed Web of Science ®Google Scholar
• Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TAJr, Jansen-McWilliams L, D'Agostino RB, Kuller LH. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study. Am J Epidemiol. 1997; 145:408–415.
   PubMed Web of Science ®Google Scholar
• Aprahamian T, Rifkin I, Bonegio R, Hugel B, Freyssinet JM, Sato K, Castellot JJJr, Walsh K. Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease. J Exp Med. 2004; 199:1121–1131.
   PubMed Web of Science ®Google Scholar
• Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, Cote R, Grover SA, Fortin PR, Clarke AE, Senecal JL. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001; 44:2331–2337.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Tanaka M, Brannan CI, Jenkins NA, Copeland NG, Suda T, Nagata S. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell. 1994; 76:969–976.
   PubMed Web of Science ®Google Scholar
• Yassin LM, Rojas M, Ramirez LA, Garcia LF, Vasquez G. Monocyte activation by apoptotic cells removal in systemic lupus erythematosus patients. Cell Immunol. 2010; 266:52–60.
   PubMed Web of Science ®Google Scholar
• Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982; 25:1271–1277.
   PubMed Web of Science ®Google Scholar
• Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH. Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. Arthritis Rheum. 1992; 35:630–640.
   PubMed Web of Science ®Google Scholar
• Wilson T, March H, Ban WJ, Hou Y, Adler S, Meyers CY, Winters TA, Maher MA. Antioxidant effects of phyto-and synthetic-estrogens on cupric ion-induced oxidation of human low-density lipoproteins in vitro. Life Sci. 2002; 70:2287–2297.
   PubMed Web of Science ®Google Scholar
• Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 1989; 6:67–75.
   PubMed Web of Science ®Google Scholar
• Bird RP, Draper HH. Comparative studies on different methods of malonaldehyde determination. Methods Enzymol. 1984; 105:299–305.
   PubMed Web of Science ®Google Scholar
• De Sanctis JB, Blanca I, Bianco NE. Expression of different lipoprotein receptors in natural killer cells and their effect on natural killer proliferative and cytotoxic activity. Immunology. 1995; 86:399–407.
   PubMed Web of Science ®Google Scholar
• Pitas RE, Innerarity TL, Weinstein JN, Mahley RW. Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arteriosclerosis. 1981; 1:177–185.
   PubMedGoogle Scholar
• Hed J, Hallden G, Johansson SG, Larsson P. The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation. J Immunol Methods. 1987; 101:119–125.
   PubMed Web of Science ®Google Scholar
• O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SKJr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med. 1999; 340:14–22.
   PubMed Web of Science ®Google Scholar
• Tomasik A, Jachec W, Skrzep-Poloczek B, Widera-Romuk E, Wodniecki J, Wojciechowska C. Circulating electronegatively charged low-density lipoprotein in patients with angiographically documented coronary artery disease. Scand J Clin Lab Invest. 2003; 63:259–265.
   PubMed Web of Science ®Google Scholar
• Frostegard J. SLE, atherosclerosis and cardiovascular disease. J Intern Med. 2005; 257:485–495.
   PubMed Web of Science ®Google Scholar
• Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97:1837–1847.
   PubMed Web of Science ®Google Scholar
• Dawber TR, Kannel WB, Revotskie N, Stokes JIII, Kagan A, Gordon T. Some factors associated with the development of coronary heart disease: Six years' follow-up experience in the Framingham study. Am J Public Health Nations Health. 1959; 49:1349–1356.
   PubMed Web of Science ®Google Scholar
• de Carvalho JF, Bonfa E, Borba EF. Systemic lupus erythematosus and ‘lupus dyslipoproteinemia’. Autoimmun Rev. 2008; 7:246–250.
   PubMed Web of Science ®Google Scholar
• Ikonomidis I, Stamatelopoulos K, Lekakis J, Vamvakou GD, Kremastinos DT. Inflammatory and non-invasive vascular markers: The multimarker approach for risk stratification in coronary artery disease. Atherosclerosis. 2008; 199:3–11.
   PubMed Web of Science ®Google Scholar
• Urowitz MB, Bookman AA, Koehler BE, Gordon DA, Smythe HA, Ogryzlo MA. The bimodal mortality pattern of systemic lupus erythematosus. Am J Med. 1976; 60:221–225.
   PubMed Web of Science ®Google Scholar
• Bruni F, Pasqui AL, Pastorelli M, Bova G, Cercignani M, Palazzuoli A, Sawamura T, Gioffre WR, Auteri A, Puccetti L. Different effect of statins on platelet oxidized-LDL receptor (CD36 and LOX-1) expression in hypercholesterolemic subjects. Clin Appl Thromb Hemost. 2005; 11:417–428.
   PubMed Web of Science ®Google Scholar
• Buechler C, Ritter M, Orso E, Langmann T, Klucken J, Schmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol. 2000; 67:97–103.
   PubMed Web of Science ®Google Scholar
• Ballou SP, Lozanski FB, Hodder S, Rzewnicki DL, Mion LC, Sipe JD, Ford AB, Kushner I. Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. Age Ageing. 1996; 25:224–230.
   PubMed Web of Science ®Google Scholar
• Yung RL, Julius A. Epigenetics, aging, and autoimmunity. Autoimmunity. 2008; 41:329–335.
   PubMed Web of Science ®Google Scholar
• Goldstein JI, Goldstein KA, Wardwell K, Fahrner SL, Goonan KE, Cheney MD, Yeager MP, Guyre PM. Increase in plasma and surface CD163 levels in patients undergoing coronary artery bypass graft surgery. Atherosclerosis. 2003; 170:325–332.
   PubMed Web of Science ®Google Scholar
• Teupser D, Stein O, Burkhardt R, Nebendahl K, Stein Y, Thiery J. Scavenger receptor activity is increased in macrophages from rabbits with low atherosclerotic response: Studies in normocholesterolemic high and low atherosclerotic response rabbits. Arterioscler Thromb Vasc Biol. 1999; 19:1299–1305.
   PubMed Web of Science ®Google Scholar
• Jalkanen J, Leppanen P, Narvanen O, Greaves DR, Yla-Herttuala S. Adenovirus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor (SR-AI) in LDL receptor knock-out mice. Atherosclerosis. 2003; 169:95–103.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Kurihara Y, Takeya M, Kamada N, Kataoka M, Jishage K, Ueda O, Sakaguchi H, Higashi T, Suzuki T, Takashima Y, Kawabe Y, Cynshi O, Wada Y, Honda M, Kurihara H, Aburatani H, Doi T, Matsumoto A, Azuma S, Noda T, Toyoda Y, Itakura H, Yazaki Y, Kodama T. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 1997; 386:292–296.
   PubMed Web of Science ®Google Scholar
• Sakaguchi H, Takeya M, Suzuki H, Hakamata H, Kodama T, Horiuchi S, Gordon S, van der Laan LJ, Kraal G, Ishibashi S, Kitamura N, Takahashi K. Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice. Lab Invest. 1998; 78:423–434.
   PubMed Web of Science ®Google Scholar
• Febbraio M, Podrez EA, Smith JD, Hajjar DP, Hazen SL, Hoff HF, Sharma K, Silverstein RL. Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest. 2000; 105:1049–1056.
   PubMed Web of Science ®Google Scholar
• Moore KJ, Kunjathoor VV, Koehn SL, Manning JJ, Tseng AA, Silver JM, McKee M, Freeman MW. Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest. 2005; 115:2192–2201.
   PubMed Web of Science ®Google Scholar
• Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989; 320:915–924.
   PubMed Web of Science ®Google Scholar
• Naito M, Suzuki H, Mori T, Matsumoto A, Kodama T, Takahashi K. Coexpression of type I and type II human macrophage scavenger receptors in macrophages of various organs and foam cells in atherosclerotic lesions. Am J Pathol. 1992; 141:591–599.
   PubMed Web of Science ®Google Scholar
• Rivas L, Zabaleta M, Toro F, Bianco NE, De Sanctis JB. Decreased transcription, expression and function of low-density lipoprotein receptor in leukocytes from patients with systemic lupus erythematosus. Autoimmunity. 2009; 42:266–268.
   PubMed Web of Science ®Google Scholar
• Hsu HY, Chiu SL, Wen MH, Chen KY, Hua KF. Ligands of macrophage scavenger receptor induce cytokine expression via differential modulation of protein kinase signaling pathways. J Biol Chem. 2001; 276:28719–28730.
   PubMed Web of Science ®Google Scholar
• Janabi M, Yamashita S, Hirano K, Sakai N, Hiraoka H, Matsumoto K, Zhang Z, Nozaki S, Matsuzawa Y. Oxidized LDL-induced NF-kappa B activation and subsequent expression of proinflammatory genes are defective in monocyte-derived macrophages from CD36-deficient patients. Arterioscler Thromb Vasc Biol. 2000; 20:1953–1960.
   PubMed Web of Science ®Google Scholar
• Martin-Fuentes P, Civeira F, Recalde D, Garcia-Otin AL, Jarauta E, Marzo I, Cenarro A. Individual variation of scavenger receptor expression in human macrophages with oxidized low-density lipoprotein is associated with a differential inflammatory response. J Immunol. 2007; 179:3242–3248.
   PubMed Web of Science ®Google Scholar
• Osterud B, Bjorklid E. Role of monocytes in atherogenesis. Physiol Rev. 2003; 83:1069–1112.
   PubMed Web of Science ®Google Scholar